Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | ST3GAL1 | Human | 1,1-dichloroethene | increases expression | ISO | St3gal1 (Mus musculus) | 6480464 | vinylidene chloride results in increased expression of ST3GAL1 mRNA | CTD | PMID:26682919 | ST3GAL1 | Human | 1,2-dimethylhydrazine | decreases expression | ISO | St3gal1 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in decreased expression of ST3GAL1 mRNA | CTD | PMID:22206623 | ST3GAL1 | Human | 17beta-estradiol | increases expression | EXP | | 6480464 | Estradiol results in increased expression of ST3GAL1 mRNA | CTD | PMID:19619570 and PMID:31614463 | ST3GAL1 | Human | 17beta-estradiol | increases expression | ISO | St3gal1 (Rattus norvegicus) | 6480464 | Estradiol results in increased expression of ST3GAL1 mRNA | CTD | PMID:32145629 | ST3GAL1 | Human | 17beta-estradiol | multiple interactions | ISO | St3gal1 (Rattus norvegicus) | 6480464 | [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ST3GAL1 mRNA | CTD | PMID:32741896 | ST3GAL1 | Human | 17beta-estradiol | increases expression | ISO | St3gal1 (Mus musculus) | 6480464 | Estradiol results in increased expression of ST3GAL1 mRNA | CTD | PMID:19484750 | ST3GAL1 | Human | 17beta-estradiol | affects expression | EXP | | 6480464 | Estradiol affects the expression of ST3GAL1 mRNA | CTD | PMID:14699072 and PMID:22574217 | ST3GAL1 | Human | 17beta-estradiol | multiple interactions | EXP | | 6480464 | [Estradiol binds to ESR2 protein] which results in increased expression of ST3GAL1 mRNA more ... | CTD | PMID:19619570 more ... | ST3GAL1 | Human | 17beta-estradiol 3-benzoate | multiple interactions | ISO | St3gal1 (Rattus norvegicus) | 6480464 | [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ST3GAL1 mRNA | CTD | PMID:32741896 | ST3GAL1 | Human | 2,2',4,4',5,5'-hexachlorobiphenyl | increases expression | EXP | | 6480464 | 2 more ... | CTD | PMID:34627992 | ST3GAL1 | Human | 2,2',4,4'-Tetrabromodiphenyl ether | affects expression | ISO | St3gal1 (Mus musculus) | 6480464 | 2 more ... | CTD | PMID:30294300 | ST3GAL1 | Human | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of ST3GAL1 mRNA | CTD | PMID:19619570 | ST3GAL1 | Human | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | St3gal1 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of ST3GAL1 mRNA | CTD | PMID:33387578 | ST3GAL1 | Human | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | St3gal1 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of ST3GAL1 mRNA | CTD | PMID:34747641 | ST3GAL1 | Human | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | St3gal1 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of ST3GAL1 mRNA | CTD | PMID:21570461 and PMID:26377647 | ST3GAL1 | Human | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of ST3GAL1 mRNA | CTD | PMID:19619570 more ... | ST3GAL1 | Human | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | St3gal1 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of ST3GAL1 mRNA | CTD | PMID:19770486 and PMID:28922406 | ST3GAL1 | Human | 2,4-dinitrotoluene | affects expression | ISO | St3gal1 (Rattus norvegicus) | 6480464 | 2 and 4-dinitrotoluene affects the expression of ST3GAL1 mRNA | CTD | PMID:21346803 | ST3GAL1 | Human | 3,3',4,4',5-pentachlorobiphenyl | increases expression | ISO | St3gal1 (Rattus norvegicus) | 6480464 | 3 more ... | CTD | PMID:23196670 | ST3GAL1 | Human | 4,4'-diaminodiphenylmethane | decreases expression | ISO | St3gal1 (Rattus norvegicus) | 6480464 | 4 and 4'-diaminodiphenylmethane results in decreased expression of ST3GAL1 mRNA | CTD | PMID:30723492 | ST3GAL1 | Human | 4,4'-sulfonyldiphenol | increases expression | ISO | St3gal1 (Mus musculus) | 6480464 | bisphenol S results in increased expression of ST3GAL1 mRNA | CTD | PMID:30951980 | ST3GAL1 | Human | 4-hydroxyphenyl retinamide | increases expression | EXP | | 6480464 | Fenretinide results in increased expression of ST3GAL1 mRNA | CTD | PMID:15958647 | ST3GAL1 | Human | 4-hydroxyphenyl retinamide | decreases expression | ISO | St3gal1 (Mus musculus) | 6480464 | Fenretinide results in decreased expression of ST3GAL1 mRNA | CTD | PMID:28973697 | ST3GAL1 | Human | 4-hydroxyphenyl retinamide | increases expression | ISO | St3gal1 (Mus musculus) | 6480464 | Fenretinide results in increased expression of ST3GAL1 mRNA | CTD | PMID:28973697 | ST3GAL1 | Human | 6-propyl-2-thiouracil | increases expression | ISO | St3gal1 (Rattus norvegicus) | 6480464 | Propylthiouracil results in increased expression of ST3GAL1 mRNA | CTD | PMID:24780913 | ST3GAL1 | Human | 8-Br-cAMP | increases expression | EXP | | 6480464 | 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of ST3GAL1 mRNA | CTD | PMID:22079614 | ST3GAL1 | Human | acetamide | decreases expression | ISO | St3gal1 (Rattus norvegicus) | 6480464 | acetamide results in decreased expression of ST3GAL1 mRNA | CTD | PMID:31881176 | ST3GAL1 | Human | aflatoxin B1 | decreases expression | ISO | St3gal1 (Mus musculus) | 6480464 | Aflatoxin B1 results in decreased expression of ST3GAL1 mRNA | CTD | PMID:19770486 | ST3GAL1 | Human | aflatoxin B1 | decreases expression | EXP | | 6480464 | Aflatoxin B1 results in decreased expression of ST3GAL1 mRNA | CTD | PMID:21641981 | ST3GAL1 | Human | all-trans-retinoic acid | increases expression | EXP | | 6480464 | Tretinoin results in increased expression of ST3GAL1 mRNA | CTD | PMID:21934132 and PMID:23830798 | ST3GAL1 | Human | antirheumatic drug | decreases expression | EXP | | 6480464 | Antirheumatic Agents results in decreased expression of ST3GAL1 mRNA | CTD | PMID:24449571 | ST3GAL1 | Human | aristolochic acid A | decreases expression | EXP | | 6480464 | aristolochic acid I results in decreased expression of ST3GAL1 mRNA | CTD | PMID:33212167 | ST3GAL1 | Human | arsane | affects methylation | EXP | | 6480464 | Arsenic affects the methylation of ST3GAL1 gene | CTD | PMID:25304211 | ST3GAL1 | Human | arsenic atom | affects methylation | EXP | | 6480464 | Arsenic affects the methylation of ST3GAL1 gene | CTD | PMID:25304211 | ST3GAL1 | Human | benzene | increases expression | EXP | | 6480464 | Benzene results in increased expression of ST3GAL1 mRNA | CTD | PMID:19162166 | ST3GAL1 | Human | benzo[a]pyrene | decreases expression | ISO | St3gal1 (Mus musculus) | 6480464 | Benzo(a)pyrene results in decreased expression of ST3GAL1 mRNA | CTD | PMID:19770486 | ST3GAL1 | Human | benzo[a]pyrene | affects methylation | EXP | | 6480464 | Benzo(a)pyrene affects the methylation of ST3GAL1 5' UTR and Benzo(a)pyrene affects the methylation of ST3GAL1 promoter | CTD | PMID:27901495 | ST3GAL1 | Human | benzo[a]pyrene | increases methylation | EXP | | 6480464 | Benzo(a)pyrene results in increased methylation of ST3GAL1 3' UTR | CTD | PMID:27901495 | ST3GAL1 | Human | benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of ST3GAL1 mRNA | CTD | PMID:26238291 | ST3GAL1 | Human | benzo[a]pyrene | increases expression | ISO | St3gal1 (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased expression of ST3GAL1 mRNA | CTD | PMID:22228805 and PMID:22610609 | ST3GAL1 | Human | benzo[a]pyrene | multiple interactions | ISO | St3gal1 (Mus musculus) | 6480464 | AHR protein affects the reaction [Benzo(a)pyrene affects the expression of ST3GAL1 mRNA] | CTD | PMID:22228805 | ST3GAL1 | Human | benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of ST3GAL1 mRNA | CTD | PMID:21802500 | ST3GAL1 | Human | benzo[a]pyrene diol epoxide I | decreases expression | EXP | | 6480464 | 7 more ... | CTD | PMID:20382639 | ST3GAL1 | Human | bis(2-ethylhexyl) phthalate | increases expression | EXP | | 6480464 | Diethylhexyl Phthalate results in increased expression of ST3GAL1 mRNA | CTD | PMID:31163220 | ST3GAL1 | Human | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of ST3GAL1 mRNA | CTD | PMID:20678512 | ST3GAL1 | Human | bisphenol A | increases expression | ISO | St3gal1 (Mus musculus) | 6480464 | bisphenol A results in increased expression of ST3GAL1 mRNA | CTD | PMID:30951980 more ... | ST3GAL1 | Human | bisphenol A | increases methylation | ISO | St3gal1 (Rattus norvegicus) | 6480464 | bisphenol A results in increased methylation of ST3GAL1 gene | CTD | PMID:28505145 | ST3GAL1 | Human | bisphenol A | increases expression | ISO | St3gal1 (Rattus norvegicus) | 6480464 | bisphenol A results in increased expression of ST3GAL1 mRNA | CTD | PMID:25181051 more ... | ST3GAL1 | Human | bisphenol A | decreases expression | ISO | St3gal1 (Mus musculus) | 6480464 | bisphenol A results in decreased expression of ST3GAL1 mRNA | CTD | PMID:26063408 | ST3GAL1 | Human | bisphenol F | increases expression | ISO | St3gal1 (Mus musculus) | 6480464 | bisphenol F results in increased expression of ST3GAL1 mRNA | CTD | PMID:30951980 | ST3GAL1 | Human | butanal | increases expression | EXP | | 6480464 | butyraldehyde results in increased expression of ST3GAL1 mRNA | CTD | PMID:26079696 | ST3GAL1 | Human | cadmium dichloride | decreases expression | EXP | | 6480464 | Cadmium Chloride results in decreased expression of ST3GAL1 mRNA | CTD | PMID:21457566 | ST3GAL1 | Human | carbon nanotube | increases expression | ISO | St3gal1 (Mus musculus) | 6480464 | Nanotubes more ... | CTD | PMID:25554681 | ST3GAL1 | Human | carbon nanotube | decreases expression | ISO | St3gal1 (Mus musculus) | 6480464 | Nanotubes and Carbon results in decreased expression of ST3GAL1 mRNA | CTD | PMID:31978390 | ST3GAL1 | Human | carmustine | affects response to substance | EXP | | 6480464 | ST3GAL1 mRNA affects the susceptibility to Carmustine | CTD | PMID:16365179 | ST3GAL1 | Human | chlormequat chloride | increases expression | ISO | St3gal1 (Rattus norvegicus) | 6480464 | Chlormequat results in increased expression of ST3GAL1 protein | CTD | PMID:34958886 | ST3GAL1 | Human | chlorpyrifos | increases expression | ISO | St3gal1 (Mus musculus) | 6480464 | Chlorpyrifos results in increased expression of ST3GAL1 mRNA | CTD | PMID:37019170 | ST3GAL1 | Human | cisplatin | increases expression | EXP | | 6480464 | Cisplatin results in increased expression of ST3GAL1 mRNA | CTD | PMID:27594783 | ST3GAL1 | Human | cisplatin | decreases expression | EXP | | 6480464 | Cisplatin results in decreased expression of ST3GAL1 mRNA | CTD | PMID:27392435 | ST3GAL1 | Human | cisplatin | multiple interactions | EXP | | 6480464 | [Cisplatin co-treated with jinfukang] results in decreased expression of ST3GAL1 mRNA | CTD | PMID:27392435 | ST3GAL1 | Human | clofibrate | decreases expression | ISO | St3gal1 (Mus musculus) | 6480464 | Clofibrate results in decreased expression of ST3GAL1 mRNA | CTD | PMID:17585979 | ST3GAL1 | Human | copper(II) sulfate | decreases expression | EXP | | 6480464 | Copper Sulfate results in decreased expression of ST3GAL1 mRNA | CTD | PMID:19549813 | ST3GAL1 | Human | coumestrol | multiple interactions | EXP | | 6480464 | [Coumestrol co-treated with resveratrol] results in decreased expression of ST3GAL1 mRNA | CTD | PMID:19167446 | ST3GAL1 | Human | crocidolite asbestos | decreases expression | ISO | St3gal1 (Mus musculus) | 6480464 | Asbestos and Crocidolite results in decreased expression of ST3GAL1 mRNA | CTD | PMID:29279043 | ST3GAL1 | Human | cyclosporin A | decreases expression | EXP | | 6480464 | Cyclosporine results in decreased expression of ST3GAL1 mRNA | CTD | PMID:25562108 | ST3GAL1 | Human | cytarabine | decreases expression | EXP | | 6480464 | Cytarabine results in decreased expression of ST3GAL1 mRNA | CTD | PMID:21198554 | ST3GAL1 | Human | disodium selenite | increases expression | EXP | | 6480464 | Sodium Selenite results in increased expression of ST3GAL1 mRNA | CTD | PMID:18175754 | ST3GAL1 | Human | dorsomorphin | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | ST3GAL1 | Human | doxorubicin | decreases expression | EXP | | 6480464 | Doxorubicin results in decreased expression of ST3GAL1 mRNA | CTD | PMID:29803840 | ST3GAL1 | Human | epoxiconazole | increases expression | ISO | St3gal1 (Mus musculus) | 6480464 | epoxiconazole results in increased expression of ST3GAL1 mRNA | CTD | PMID:35436446 | ST3GAL1 | Human | ethanol | affects expression | ISO | St3gal1 (Mus musculus) | 6480464 | Ethanol affects the expression of ST3GAL1 mRNA | CTD | PMID:30319688 | ST3GAL1 | Human | ethyl methanesulfonate | decreases expression | EXP | | 6480464 | Ethyl Methanesulfonate results in decreased expression of ST3GAL1 mRNA | CTD | PMID:23649840 | ST3GAL1 | Human | furan | decreases expression | ISO | St3gal1 (Rattus norvegicus) | 6480464 | furan results in decreased expression of ST3GAL1 mRNA | CTD | PMID:25539665 | ST3GAL1 | Human | gentamycin | decreases expression | ISO | St3gal1 (Rattus norvegicus) | 6480464 | Gentamicins results in decreased expression of ST3GAL1 mRNA | CTD | PMID:33387578 | ST3GAL1 | Human | lead diacetate | multiple interactions | EXP | | 6480464 | [lead acetate co-treated with zinc protoporphyrin] results in increased expression of ST3GAL1 mRNA | CTD | PMID:22839698 | ST3GAL1 | Human | lithocholic acid | multiple interactions | EXP | | 6480464 | Lithocholic Acid analog results in decreased expression of and results in decreased activity of ST3GAL1 protein | CTD | PMID:21224350 | ST3GAL1 | Human | methamphetamine | increases expression | ISO | St3gal1 (Mus musculus) | 6480464 | Methamphetamine results in increased expression of ST3GAL1 mRNA | CTD | PMID:26307267 | ST3GAL1 | Human | methotrexate | affects expression | ISO | St3gal1 (Mus musculus) | 6480464 | Methotrexate affects the expression of ST3GAL1 mRNA | CTD | PMID:18502557 | ST3GAL1 | Human | methotrexate | decreases expression | EXP | | 6480464 | Methotrexate results in decreased expression of ST3GAL1 mRNA | CTD | PMID:24449571 | ST3GAL1 | Human | methyl methanesulfonate | decreases expression | EXP | | 6480464 | Methyl Methanesulfonate results in decreased expression of ST3GAL1 mRNA | CTD | PMID:23649840 | ST3GAL1 | Human | nickel atom | increases expression | EXP | | 6480464 | Nickel results in increased expression of ST3GAL1 mRNA | CTD | PMID:24768652 and PMID:25583101 | ST3GAL1 | Human | panobinostat | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ST3GAL1 mRNA | CTD | PMID:27188386 | ST3GAL1 | Human | panobinostat | increases expression | EXP | | 6480464 | panobinostat results in increased expression of ST3GAL1 mRNA | CTD | PMID:26272509 | ST3GAL1 | Human | paracetamol | affects expression | ISO | St3gal1 (Mus musculus) | 6480464 | Acetaminophen affects the expression of ST3GAL1 mRNA | CTD | PMID:17562736 | ST3GAL1 | Human | paracetamol | decreases expression | ISO | St3gal1 (Rattus norvegicus) | 6480464 | Acetaminophen results in decreased expression of ST3GAL1 mRNA | CTD | PMID:33387578 | ST3GAL1 | Human | pentachlorophenol | increases expression | ISO | St3gal1 (Mus musculus) | 6480464 | Pentachlorophenol results in increased expression of ST3GAL1 mRNA | CTD | PMID:23892564 | ST3GAL1 | Human | phenobarbital | affects expression | EXP | | 6480464 | Phenobarbital affects the expression of ST3GAL1 mRNA | CTD | PMID:19159669 | ST3GAL1 | Human | phenobarbital | affects expression | ISO | St3gal1 (Mus musculus) | 6480464 | Phenobarbital affects the expression of ST3GAL1 mRNA | CTD | PMID:23091169 | ST3GAL1 | Human | phenylmercury acetate | increases expression | EXP | | 6480464 | Phenylmercuric Acetate results in increased expression of ST3GAL1 mRNA | CTD | PMID:26272509 | ST3GAL1 | Human | phenylmercury acetate | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ST3GAL1 mRNA | CTD | PMID:27188386 | ST3GAL1 | Human | pioglitazone | multiple interactions | EXP | | 6480464 | [pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of ST3GAL1 mRNA and pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ST3GAL1 mRNA] | CTD | PMID:20847119 | ST3GAL1 | Human | pirinixic acid | decreases expression | ISO | St3gal1 (Mus musculus) | 6480464 | pirinixic acid results in decreased expression of ST3GAL1 mRNA | CTD | PMID:23811191 | ST3GAL1 | Human | potassium chromate | decreases expression | EXP | | 6480464 | potassium chromate(VI) results in decreased expression of ST3GAL1 mRNA | CTD | PMID:22714537 | ST3GAL1 | Human | pregnenolone 16alpha-carbonitrile | increases expression | ISO | St3gal1 (Mus musculus) | 6480464 | Pregnenolone Carbonitrile results in increased expression of ST3GAL1 mRNA | CTD | PMID:28903501 | ST3GAL1 | Human | progesterone | multiple interactions | EXP | | 6480464 | [Estradiol co-treated with Progesterone] results in decreased expression of ST3GAL1 mRNA | CTD | PMID:20660070 | ST3GAL1 | Human | propanal | increases expression | EXP | | 6480464 | propionaldehyde results in increased expression of ST3GAL1 mRNA | CTD | PMID:26079696 | ST3GAL1 | Human | raloxifene | multiple interactions | EXP | | 6480464 | [Raloxifene Hydrochloride co-treated with ESR2 protein] results in decreased expression of ST3GAL1 mRNA | CTD | PMID:19059307 | ST3GAL1 | Human | resveratrol | multiple interactions | EXP | | 6480464 | [Coumestrol co-treated with Resveratrol] results in decreased expression of ST3GAL1 mRNA and [Plant Extracts co-treated with Resveratrol] results in decreased expression of ST3GAL1 mRNA | CTD | PMID:19167446 and PMID:23557933 | ST3GAL1 | Human | rotenone | affects expression | ISO | St3gal1 (Rattus norvegicus) | 6480464 | Rotenone affects the expression of ST3GAL1 mRNA | CTD | PMID:28374803 | ST3GAL1 | Human | SB 431542 | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | ST3GAL1 | Human | silicon dioxide | increases expression | EXP | | 6480464 | Silicon Dioxide analog results in increased expression of ST3GAL1 mRNA | CTD | PMID:25895662 | ST3GAL1 | Human | sodium arsenite | increases expression | EXP | | 6480464 | sodium arsenite results in increased expression of ST3GAL1 mRNA | CTD | PMID:38568856 | ST3GAL1 | Human | sodium arsenite | decreases expression | ISO | St3gal1 (Rattus norvegicus) | 6480464 | sodium arsenite results in decreased expression of ST3GAL1 mRNA | CTD | PMID:35314868 | ST3GAL1 | Human | sotorasib | multiple interactions | EXP | | 6480464 | [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of ST3GAL1 mRNA | CTD | PMID:36139627 | ST3GAL1 | Human | succimer | multiple interactions | ISO | St3gal1 (Mus musculus) | 6480464 | [Succimer binds to Magnetite Nanoparticles] which results in increased expression of ST3GAL1 mRNA and [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ST3GAL1 mRNA | CTD | PMID:21641980 and PMID:26378955 | ST3GAL1 | Human | tamoxifen | multiple interactions | EXP | | 6480464 | [Tamoxifen co-treated with ESR2 protein] results in decreased expression of ST3GAL1 mRNA | CTD | PMID:19059307 | ST3GAL1 | Human | temozolomide | affects response to substance | EXP | | 6480464 | ST3GAL1 mRNA affects the susceptibility to temozolomide | CTD | PMID:16365179 | ST3GAL1 | Human | tert-butyl hydroperoxide | multiple interactions | EXP | | 6480464 | [pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of ST3GAL1 mRNA more ... | CTD | PMID:20847119 | ST3GAL1 | Human | tert-butyl hydroperoxide | increases expression | EXP | | 6480464 | tert-Butylhydroperoxide results in increased expression of ST3GAL1 mRNA | CTD | PMID:20847119 | ST3GAL1 | Human | testosterone | multiple interactions | ISO | St3gal1 (Rattus norvegicus) | 6480464 | [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ST3GAL1 mRNA | CTD | PMID:32741896 | ST3GAL1 | Human | tetrachloromethane | affects expression | ISO | St3gal1 (Mus musculus) | 6480464 | Carbon Tetrachloride affects the expression of ST3GAL1 mRNA | CTD | PMID:17484886 | ST3GAL1 | Human | tetrachloromethane | increases expression | ISO | St3gal1 (Mus musculus) | 6480464 | Carbon Tetrachloride results in increased expression of ST3GAL1 mRNA | CTD | PMID:31919559 | ST3GAL1 | Human | tetracycline | increases expression | ISO | St3gal1 (Mus musculus) | 6480464 | Tetracycline results in increased expression of ST3GAL1 mRNA | CTD | PMID:16917069 | ST3GAL1 | Human | thioacetamide | increases expression | ISO | St3gal1 (Rattus norvegicus) | 6480464 | Thioacetamide results in increased expression of ST3GAL1 mRNA | CTD | PMID:34492290 | ST3GAL1 | Human | thiram | increases expression | EXP | | 6480464 | Thiram results in increased expression of ST3GAL1 mRNA | CTD | PMID:38568856 | ST3GAL1 | Human | titanium dioxide | decreases methylation | ISO | St3gal1 (Mus musculus) | 6480464 | titanium dioxide results in decreased methylation of ST3GAL1 gene and titanium dioxide results in decreased methylation of ST3GAL1 promoter | CTD | PMID:35295148 | ST3GAL1 | Human | trametinib | multiple interactions | EXP | | 6480464 | [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of ST3GAL1 mRNA | CTD | PMID:36139627 | ST3GAL1 | Human | triphenyl phosphate | decreases expression | ISO | St3gal1 (Rattus norvegicus) | 6480464 | triphenyl phosphate results in decreased expression of ST3GAL1 mRNA | CTD | PMID:30589522 | ST3GAL1 | Human | triphenyl phosphate | affects expression | EXP | | 6480464 | triphenyl phosphate affects the expression of ST3GAL1 mRNA | CTD | PMID:37042841 | ST3GAL1 | Human | troglitazone | multiple interactions | EXP | | 6480464 | [troglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of ST3GAL1 mRNA and troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ST3GAL1 mRNA] | CTD | PMID:20847119 | ST3GAL1 | Human | tungsten | decreases expression | ISO | St3gal1 (Mus musculus) | 6480464 | Tungsten results in decreased expression of ST3GAL1 mRNA | CTD | PMID:30912803 | ST3GAL1 | Human | valproic acid | affects expression | ISO | St3gal1 (Mus musculus) | 6480464 | Valproic Acid affects the expression of ST3GAL1 mRNA | CTD | PMID:17963808 | ST3GAL1 | Human | zinc protoporphyrin | multiple interactions | EXP | | 6480464 | [lead acetate co-treated with zinc protoporphyrin] results in increased expression of ST3GAL1 mRNA | CTD | PMID:22839698 | |